Suppr超能文献

海藻酸钠水凝胶作为透明质酸的潜在替代品,可作为黏膜下注射材料。

Alginate hydrogel as a potential alternative to hyaluronic acid as submucosal injection material.

机构信息

Department of Medicine, Hallym University College of Medical School, Hallym University Sacred Heart Hospital, Anyang, Korea.

出版信息

Dig Dis Sci. 2013 Jun;58(6):1491-6. doi: 10.1007/s10620-012-2555-z. Epub 2013 Jan 24.

Abstract

BACKGROUND

Sodium alginate is currently used in medical products, including drugs and cosmetic materials. It can also be used as a submucosal injection material due to its excellent water retention ability. Alginate with a high water retention ability is called alginate hydrogel (AH). The aim of this study was to investigate the usefulness of AH as a submucosal injection material.

METHODS

To investigate the optimal viscosity of AH as a submucosal injection material, we observed the changes in submucosal height from the initial submucosal height in the stomachs of six miniature pigs for each injection material tested (0.3 % AH, 0.5 % hyaluronic acid, glycerol). All submucosal heights were compared serially over time (3, 5, 10, 20, and 30 min). Both immediate and 1-week delayed tissue reactions were investigated endoscopically in the same living pigs. Histological analyses were performed after the animals had been sacrificed.

RESULTS

In a preliminary study, we determined that 0.3 % sodium alginate mixed with BaCl2 (400 μl) was the optimal viscosity of AH as an injection material. Our comparison of submucosal height changes over time showed that there was a significant decrease in submucosal height just 3 min following the injection of hyaluronic acid and glycerol, but that following the injection of AH a significant decrease in submucosal height was observed only after 10 min (p < 0.05). The histological analyses revealed that there were mild capillary dilations with congestion and mild fibrotic changes with some lymphocytic infiltration at the AH injection site.

CONCLUSION

Alginate hydrogel demonstrated long-lasting maintenance of submucosal elevation, safety, and cost-effectiveness in a pig model, which makes it a potential alternative to hyaluronic acid.

摘要

背景

海藻酸钠目前被应用于医疗产品,包括药物和化妆品材料。由于其优异的保水能力,它也可以作为黏膜下注射材料。保水能力高的海藻酸盐称为海藻酸钠水凝胶(AH)。本研究旨在探讨 AH 作为黏膜下注射材料的有效性。

方法

为了研究 AH 作为黏膜下注射材料的最佳黏度,我们观察了 6 头小型猪每一种注射材料(0.3%AH、0.5%透明质酸、甘油)的黏膜下高度从初始黏膜下高度的变化。所有黏膜下高度均随时间(3、5、10、20 和 30 分钟)进行连续比较。在同一头活猪中,我们还分别进行了即刻和 1 周延迟的组织反应的内镜检查。动物死后进行组织学分析。

结果

在初步研究中,我们确定 0.3%海藻酸钠与 BaCl2(400μl)混合是 AH 作为注射材料的最佳黏度。我们对黏膜下高度随时间的变化进行了比较,结果表明,透明质酸和甘油注射后仅 3 分钟,黏膜下高度就显著下降,而 AH 注射后仅 10 分钟才观察到黏膜下高度显著下降(p<0.05)。组织学分析显示,AH 注射部位有轻微的毛细血管扩张伴充血,轻微的纤维化改变,伴有一些淋巴细胞浸润。

结论

海藻酸钠水凝胶在猪模型中显示出黏膜下隆起的持久维持、安全性和成本效益,使其成为透明质酸的潜在替代品。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验